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Abstract
Eleven cases of malignant lymphomas were treated with a fibroblast-inhibiting agent, chloro-
quine, and of these, one case of lymphosarcoma, two of acute and chronic lymphocytic leukemia,
respectively, and two of giant follicle lymphoma showed regression of the enlarged lymph nodes
and also of the enlarged spleen in some of the splenomegalic patients. In contrast, the drug proved
ineffective in two cases of reticulum cell sarcoma and Hodgkin’s disease, respectively. The side
effects of the drug were minimal, and three of the 11 cases complained of nausea, anorexia or
palpebral ptosis, which disappeared by decreasing the drug dosage or combining ATP preparation.
The tissue culture study of biopsied lymph nodes from lymphocytic leukemia showed inhibition
of the growth zone in a medium containing chloroquine indicating a possibility of the drug action
not only upon the stromal tissue but also upon the parenchymal tumor cell.
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In the preceding papers we described our unique approach to cancer
chemotherapy in which a fibroblast-inhibiting agent, chloroquine, was used
against various human and animal tumors with considerable therapeutic
effects.1.2·3,u.6 The mechanism of the drug action appeared to be in the inhibition
of the growth of stromal connective tissue leading secondarily to the damage of
parenchymal tumor cells. Importance of its possible anti-inflammatory and
humoral effects upon the host was also discussed.
The present experiment was initiated on a speculation that chloropuine
might also be effective against malignant lymphomas having the same meso-
dermal origin as fibroblasts which are particularly sensitive to the drug. In this
paper are presented the results of chloroquine treatment in malignant lymphomas
and effects of chloroquine on biopsied lymph node cultured in vitro.
MATERIALS AND METHODS
A total of 11 cases of malignant lymphomas were studied and included one
case of lymphosarcoma, two of acute lymphocytic leukemia, two of chronic lym-
phocytic leukemia, two of giant follicle lymphoma, two of reticulum cell sarcoma,
and two of Hodgkin's disease.
As a fibroblast-inhibiting agent, either 250 mg of chloroquine diphosphate
or 200mg of chloroquine diorotate were administered slowly by an intravenous
route, usually once or twice daily, and the longest duration of therapy ever
attained was 14 months. Many other patients are still placed on the continued
treatment.
The treatment effects were evaluated, as in carcinoma patients, according
to the degrees of objective and subjective improvement and classifed as effec-
tive, slightly effective and non-effective.3.6
RESULTS
A 63-year-old male with a history of generalized lymphadenopathy of 3
years' duration was hospitalized in a severely ill condition with pleural effusion,
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ascites and pretibial edema. As shown in the Fig. 1, there were many 2 to 5 cm
lymph nodes in the right side of the neck, both axilla and groins. He had
pleural effusion on the right and marked ascites. The liver was palpable 2
fingerbreadths and spleen 8 fingerbreadths down the costal margin. Enlarged
mesenteric lymph nodes were also palpable around the umbilicus.
Table1 Therapeutic effect of chloroquine on malignant lymphomas
I No. cases I Enlarged lymph node I Enlarged spleen
Lymphosarcoma 1 Regression
I
Regression
Acute lymphocytic leukemia 2 1/
I
No change
Chronic lymphocytic leukemia 2 1/ 1/
Giant follicle lymphoma 2 // /
Pleural
effusloD
AscItes
Before treatmentl
Fig. 1 Therapeutic effect of chloroquine on lymphosarcoma
Laboratory examination revealed moderate anemia, and hemorrhagic ascites
with a strongly positive TPT reaction. Biopsied axillary lymph nodes showed
lymphosarcoma.
He was started on 200 mg of chloroquine diorotate twice daily, and after
one week the enlarged lymph nodes began to regress and after about one month
they were hardly palpable. The spleen became smaller and was palpable 4
fingerbreadths below the costal margin. There was a gradual decrease of both
pleural and ascitic effusions. His appetite returned and there was an increase of
his body weight. After about 6 months' treatment, he was discharged to· be
followed in the clinic. On his return visit after 14 months of treatment, he con-
tinued to be in a satisfactory condition (Figs. 1, 2).
Histological comparison of biopsied lymph nodes indicated that before treat-
ment there was a diffuse proliferation of lymphosarcoma cells completely obli-
terating the normal structure while 4 months after treatment there was a decrease
of the infiltrating lymphosarcoma cells with a tendency to structural normaliza-
tion."
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Chloroquine
diorotate
No. months
Anorexia
Abdominal fullness
Pressure sensation
of the chest
Abdomen
Ascites tt+ + ± ± ±
15
Fig. 2 Lymphosarcoma, 1. S. 64y. 0
In one patient with acute lymphocytic leukemia, enlarged cervical lymph
nodes on both sides began to regress after 3 -4 days of chloroquine diphosphate
treatmant. In the other case of acute lymphocytic leukemia, only the cervical
lymph nodes became smaller after 4 - 5 days of treatment, but there was no res-
ponse of the axillary and inguinal groups.
One case of chronic lymphocytic leukemia had a pigeon's-egg-sized mass in
the right supraclavicular region which became smaller after about one week of
treatment. The other case of chronic lymphocytic leukemia with bilateral cervical
lymph node enlargement showed regression of the lymph node after one week of
treatment. These 4 cases of lymphocytic leukemia are still under observation
and none of them has thus far showed significant hematological changes.
In two cases of giant follicle lymphoma, there was generalized lymph-
adenopathy, which showed a distinct regression after treatment. In the first case,
for instance, regression of the enlarged lymph nodes was noted after one week
and in the second case after 3 weeks from the start of treatment. Both cases were
discharged in a state of continued remission. A lymph node biopsy specimen from
the second case after 2 months of treatment revealed only chronic inflammation,
showing improvement in comparison with the pre-treatment specimen.
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--~Control
x·· ->< Group added With 20,..,- of chloroqUine
6-·_·--.0 Group added with 2000)'i. of chloroquine
In two cases of reticulum cell sarcoma and Hodgkin's disease, respectively,
no significant improvement was obtained by treatment, and this point is now
under investigation.
The side effects of the drug were slight. Three of the 11 patients complained
of nausea, anorexia or palpebral ptosis, but could continue the drug by decreasing
the dosage or combining ATP preparation.
LYmph node tissue obtained from one case of acute and chronic lymphocytic
leukemia was cultured using Hiraki's tissue culture slides No. 2 7 in a medium con-
taining chloroquine. At the chloroquine concentration of over 20'Y %, inhibition
of the growth zone was noted, more so in the chronic form than in the acute
form (Figs. 3, 4).
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Fig. 3 Relative growth rate of leukemic cells in tissue culture of lymph
node of acute lymphocytic leukemia added with chloroquine
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Fig. 4 Relative growth rate of leukemic cells in tissue culture of lymph
node of chronic lymphocytic leukemia added with chloroquine
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DISCUSSION
Having obtained favorable therapeutic effects of chloroquine in cancer pa-
tients, we have used the drug in the treatment of malignant lymphomas, and
observed regression of the enlarged lymph nodes and spleen in lymphosarcoma,
lymphocytic leukemia and giant follicle lymphoma.
From the fact that chloroquine exerts deleterious effects on fibroblasts, the
drug was employed in the hope to induce similar effects on immature lymphoid
cells having the same mesodermal origin. These predicted effects of chloroquine
appear to have been substantiated by the findings of tissue culture and histolo-
gical studies of biopsied lymph nodes.
Our previous study using normal rabbit bone marrow cells indicated that
chloroquine exerted no influences at the concentrations of 2 and 20"1 %, and in-
hibition of their growth was noted at the concentration of over 200 y %8. On the
other hand, the growth of cultured lymph node tissue from lymphocytic leukemia
was found to be suppressed at the medium concentration of 20y %, suggesting
an excellent in vivo action of the drug in this disease. Serum chloroquine levels
in humans after administration of 250 mg of chloroquine diphosphate varied con-
siderably from case to case, but were between 25 and 75 y % 5 minutes after
intravenous injection of the drug, being far below the level of 200"1 % known to
be toxic to normal bone marrow cells. Therefore, our present method of drug
administration is considered to provide the effective serum levels against lymphoid
cells as well as fibroblasts without doing any harm to normal bone marrow ele-
ments. In other words, the drug is working not only upon stromal fibroblasts
but also upon parenchymal tumor cells.
SUMMARY
Eleven cases of malignant lymphomas were treated with a fibroblast-inhibit-
ing agent, chloroquine, and of these, one case of lymphosarcoma, two of acute
and chronic lymphocytic leukemia, respectively, and two of giant follicle lym-
phoma showed regression of the enlarged lymph nodes and also of the enlarged
spleen in some of the splenomegalic patients. In contrast, the drug proved ineffec-
tive in two cases of reticulum cell sarcoma and Hodgkin's disease, respectively.
The side effects of the drug were minimal, and three of the 11 cases com-
plained of nausea, anorexia or palpebral ptosis, which disappeared by decreasing
the drug dosage or combining ATP preparation.
The tissue culture study of biopsied lymph nodes from lymphocytic leukemia
showed inhibition of the growth zone in a medium containing chloroquine in-
dicating a possibility of the drug action not only upon the stromal tissue but also
upon the parenchymal tumor cell.
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